274 related articles for article (PubMed ID: 21849283)
41. Virulence of a novel reassortant canine H3N2 influenza virus in ferret, dog and mouse models.
Lyoo KS; Na W; Yeom M; Jeong DG; Kim CU; Kim JK; Song D
Arch Virol; 2016 Jul; 161(7):1915-23. PubMed ID: 27138550
[TBL] [Abstract][Full Text] [Related]
42. Effect of reassortment on the nucleotide and amino acid changes of human A/H3N2 RNP subunits during 1998-2009.
Wong KK; Bull RA; Stelzer-Braid S; Fennell M; Rawlinson W
J Clin Virol; 2011 Aug; 51(4):270-5. PubMed ID: 21665531
[TBL] [Abstract][Full Text] [Related]
43. CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model.
Jiang T; Zhao H; Li XF; Deng YQ; Liu J; Xu LJ; Han JF; Cao RY; Qin ED; Qin CF
Antiviral Res; 2011 Jan; 89(1):124-6. PubMed ID: 21115063
[TBL] [Abstract][Full Text] [Related]
44. Evolutionary complexities of swine flu H1N1 gene sequences of 2009.
Sinha NK; Roy A; Das B; Das S; Basak S
Biochem Biophys Res Commun; 2009 Dec; 390(3):349-51. PubMed ID: 19769939
[TBL] [Abstract][Full Text] [Related]
45. The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian influenza viruses.
Gao H; Sun Y; Hu J; Qi L; Wang J; Xiong X; Wang Y; He Q; Lin Y; Kong W; Seng LG; Sun H; Pu J; Chang KC; Liu X; Liu J
Sci Rep; 2015 Feb; 5():8262. PubMed ID: 25652161
[TBL] [Abstract][Full Text] [Related]
46. Avian influenza A virus PB2 promotes interferon type I inducing properties of a swine strain in porcine dendritic cells.
Ocaña-Macchi M; Ricklin ME; Python S; Monika GA; Stech J; Stech O; Summerfield A
Virology; 2012 May; 427(1):1-9. PubMed ID: 22365327
[TBL] [Abstract][Full Text] [Related]
47. In vivo reassortment of influenza viruses.
Urbaniak K; Markowska-Daniel I
Acta Biochim Pol; 2014; 61(3):427-31. PubMed ID: 25180223
[TBL] [Abstract][Full Text] [Related]
48. Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses.
Li C; Hatta M; Watanabe S; Neumann G; Kawaoka Y
J Virol; 2008 Dec; 82(23):11880-8. PubMed ID: 18815312
[TBL] [Abstract][Full Text] [Related]
49. Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine.
Anhlan D; Hrincius ER; Scholtissek C; Ludwig S
Vaccine; 2012 Jun; 30(30):4480-9. PubMed ID: 22575164
[TBL] [Abstract][Full Text] [Related]
50. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.
Belser JA; Wadford DA; Pappas C; Gustin KM; Maines TR; Pearce MB; Zeng H; Swayne DE; Pantin-Jackwood M; Katz JM; Tumpey TM
J Virol; 2010 May; 84(9):4194-203. PubMed ID: 20181710
[TBL] [Abstract][Full Text] [Related]
51. Dose-response assessment for influenza A virus based on data sets of infection with its live attenuated reassortants.
Watanabe T; Bartrand TA; Omura T; Haas CN
Risk Anal; 2012 Mar; 32(3):555-65. PubMed ID: 21977924
[TBL] [Abstract][Full Text] [Related]
52. Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice.
Seyer R; Hrincius ER; Ritzel D; Abt M; Mellmann A; Marjuki H; Kühn J; Wolff T; Ludwig S; Ehrhardt C
J Infect Dis; 2012 Jan; 205(2):262-71. PubMed ID: 22102733
[TBL] [Abstract][Full Text] [Related]
53. Molecular Determinants of Virulence and Stability of a Reporter-Expressing H5N1 Influenza A Virus.
Zhao D; Fukuyama S; Yamada S; Lopes TJ; Maemura T; Katsura H; Ozawa M; Watanabe S; Neumann G; Kawaoka Y
J Virol; 2015 Nov; 89(22):11337-46. PubMed ID: 26339046
[TBL] [Abstract][Full Text] [Related]
54. Characteristic amino acid changes of influenza A(H1N1)pdm09 virus PA protein enhance A(H7N9) viral polymerase activity.
Liu J; Huang F; Zhang J; Tan L; Lu G; Zhang X; Zhang H
Virus Genes; 2016 Jun; 52(3):346-53. PubMed ID: 26980671
[TBL] [Abstract][Full Text] [Related]
55. Novel reassortant influenza viruses between pandemic (H1N1) 2009 and other influenza viruses pose a risk to public health.
Kong W; Wang F; Dong B; Ou C; Meng D; Liu J; Fan ZC
Microb Pathog; 2015 Dec; 89():62-72. PubMed ID: 26344393
[TBL] [Abstract][Full Text] [Related]
56. PB2 residue 158 is a pathogenic determinant of pandemic H1N1 and H5 influenza a viruses in mice.
Zhou B; Li Y; Halpin R; Hine E; Spiro DJ; Wentworth DE
J Virol; 2011 Jan; 85(1):357-65. PubMed ID: 20962098
[TBL] [Abstract][Full Text] [Related]
57. Possible outcomes of reassortment in vivo between wild type and live attenuated influenza vaccine strains.
Kiseleva I; Dubrovina I; Bazhenova E; Fedorova E; Larionova N; Rudenko L
Vaccine; 2012 Dec; 30(51):7395-9. PubMed ID: 23063833
[TBL] [Abstract][Full Text] [Related]
58. Reassortment between seasonal H1N1 and pandemic (H1N1) 2009 influenza viruses is restricted by limited compatibility among polymerase subunits.
Octaviani CP; Goto H; Kawaoka Y
J Virol; 2011 Aug; 85(16):8449-52. PubMed ID: 21680507
[TBL] [Abstract][Full Text] [Related]
59. The 2009 pandemic H1N1 influenza virus is more pathogenic in pregnant mice than seasonal H1N1 influenza virus.
Kim HM; Kang YM; Song BM; Kim HS; Seo SH
Viral Immunol; 2012 Oct; 25(5):402-10. PubMed ID: 22985287
[TBL] [Abstract][Full Text] [Related]
60. Human intestinal epithelial cells are susceptible to influenza virus subtype H9N2.
Qu B; Li X; Gao W; Sun W; Jin Y; Cardona CJ; Xing Z
Virus Res; 2012 Jan; 163(1):151-9. PubMed ID: 21986059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
